The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Editas Medicine Inc shares valued at $7,030 were sold by Lucera Erick on Mar 04 ’25. At $1.71 per share, Lucera Erick sold 4,109 shares. The insider’s holdings dropped to 112,720 shares worth approximately $0.15 million following the completion of this transaction.
Also, O’Neill Gilmore Neil sold 16,632 shares, netting a total of over 28,452 in proceeds. Following the sale of shares at $1.71 each, the insider now holds 295,474 shares.
Before that, Burkly Linda had sold 2,891 shares from its account. In a trade valued at $4,946, the EVP, CHIEF SCIENTIFIC OFFICER traded Editas Medicine Inc shares for $1.71 each. Upon closing the transaction, the insider’s holdings decreased to 2,891 shares, worth approximately $96235.65000000001.
As published in a research note from JP Morgan on December 16, 2024, Editas Medicine Inc [EDIT] has been rated down from a Neutral to an Underweight. Analysts at Truist downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in mid December. As of December 13, 2024, Stifel has decreased its “Buy” rating to a “Hold” for EDIT. Earlier on December 13, 2024, Chardan Capital Markets downgraded its rating. Their new recommendation was “a Neutral” for EDIT stock which previously was a “a Buy”.
Analyzing EDIT Stock Performance
During the last five days, there has been a drop of approximately -23.03%. Over the course of the year, Editas Medicine Inc shares have jumped approximately 7.87%. Shares of the company reached a 52-week high of $3.2999 on 02/19/25 and a 52-week low of $1.1200 on 02/11/25. A 50-day SMA is recorded $1.4960, while a 200-day SMA reached $3.1990.
Support And Resistance Levels for Editas Medicine Inc (EDIT)
According to the 24-hour chart, there is a support level at 1.3000, which, if violated, would cause prices to drop to 1.2300. In the upper region, resistance lies at 1.5000. The next price resistance is at 1.6300. RSI (Relative Strength Index) is 43.22 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.2964, which suggests the price will decrease in the coming days. Percent R is at 98.92%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
